Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system.
Phio Pharmaceuticals stock last closed at $2.04, down 8.52% from the previous day, and has decreased 67.89% in one year. It has overperformed other stocks in the Biotechnology industry by 0.1 percentage points. Phio Pharmaceuticals stock is currently +111.18% from its 52-week low of $0.97, and -79.16% from its 52-week high of $9.79.
As of Apr 25, 2025, there are 4.78M shares of PHIO outstanding. The market cap of PHIO is $9.75M. In the past 24 hours, 444,231 PHIO shares were traded.
How to Buy Phio Pharmaceuticals Stock
Not sure how to invest in Phio Pharmaceuticals stock? Here's how.
Figure out where to buy Phio Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Phio Pharmaceuticals stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Put funds into your investment account: Choose your method of payment and add your details.
Evaluate Phio Pharmaceuticals stock: The Phio Pharmaceuticals ticker symbol is PHIO. Is Phio Pharmaceuticals stock a good investment? Should you buy shares of PHIO? How do PHIO's underlying business fundamentals look? Do top analysts think Phio Pharmaceuticals is a good buy? Why has PHIO's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if PHIO is a good stock to buy).
Make your PHIO purchase: Decide if you will purchase PHIO shares at the current market price or use a limit order to buy PHIO stock at a particular price.
Keep an eye on your PHIO position: Create a watchlist to keep track of your position in Phio Pharmaceuticals stock.
Step 1: Figure out where to buy Phio Pharmaceuticals stock
You need an online brokerage account to access the NASDAQ market and buy PHIO stock.
A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global financial markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal information so you can buy PHIO stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Phio Pharmaceuticals stock
Once you have selected the best place to buy Phio Pharmaceuticals stock, it's very important to research their stock before you buy, so you can understand the risk and opportunity.
Phio Pharmaceuticals stock at a glance
PHIO Price
$2.04
1w %
-27.92%
1y %
-67.89%
5y %
-98.98%
P/E
-0.22x
P/B
2.06x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$7.15M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$9.75M
Next Earnings
May 7, 2025
Next Dividend
N/A
Phio Pharmaceuticals Due Diligence Checks
WallStreetZen was created to help part-time investors do more accurate fundamental analysis quickly.
Last year, PHIO revenue was $0.00. Over the last 5 year, PHIO's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 45.84%.
No, Phio Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about PHIO?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your PHIO purchase
You have two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a specific dollar amount limit, place a limit order.
Press the Open Trade button and eToro will execute your order.
If you want more help investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Phio Pharmaceuticals share?
As of Apr 25, 2025, it costs $2.04 to buy one share of Phio Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.49 shares of PHIO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.